{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:07:38Z","timestamp":1789556858655,"version":"build-2803163510"},"reference-count":16,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T00:00:00Z","timestamp":1221004800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0000289","type":"journal-article","created":{"date-parts":[[2008,9,9]],"date-time":"2008-09-09T16:27:26Z","timestamp":1220977646000},"page":"e289","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Therapeutic Effect of a Novel Oxazolidinone, DA-7867, in BALB\/c Mice Infected with Nocardia brasiliensis"],"prefix":"10.1371","volume":"2","author":[{"given":"Lucio","family":"Vera-Cabrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Daw-Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Said-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector Gerardo","family":"Lozano-Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi Waksman","family":"de Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma Cavazos","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ocampo-Candiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hak","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliverio","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,9,10]]},"reference":[{"key":"ref1","first-page":"477","article-title":"[Epidemiology of mycetoma in Mexico: study of 2105 cases].","volume":"128","author":"R Lopez Martinez","year":"1992","journal-title":"Gac Med Mex"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.clindermatol.2006.05.011","article-title":"Mycetoma.","volume":"25","author":"O Welsh","year":"2007","journal-title":"Clin Dermatol"},{"key":"ref3","article-title":"Abstr. 15th Cong. Int. Soc. Human and Anim. Mycol., abstr. 354, San Antonio, Texas.","author":"O Welsh","year":"2003"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijantimicag.2003.11.003","article-title":"Oxazolidinones: activity, mode of action, and mechanism of resistance.","volume":"23","author":"B Bozdogan","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/AAC.48.2.602-604.2004","article-title":"In vitro activities of new antimicrobials against <italic>Nocardia brasiliensis<\/italic>.","volume":"48","author":"L Vera-Cabrera","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1128\/AAC.48.3.1037-1039.2004","article-title":"In vitro activities of new quinolones and oxazolidinones against <italic>Actinomadura madurae<\/italic>.","volume":"48","author":"L Vera-Cabrera","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1128\/AAC.49.10.4351-4353.2005","article-title":"In vitro susceptibility of <italic>Mycobacterium tuberculosis<\/italic> clinical isolates to garenoxacin and DA-7867.","volume":"49","author":"L Vera-Cabrera","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1128\/AAC.48.3.832-837.2004","article-title":"In vitro and in vivo activities of antimicrobials against <italic>Nocardia brasiliensis<\/italic>.","volume":"48","author":"A Gomez-Flores","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1086\/345907","article-title":"Clinical experience with linezolid for the treatment of nocardia infection.","volume":"36","author":"EH Moylett","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jac\/dkl298","article-title":"Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.","volume":"58","author":"IN Park","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/molecules13010031","article-title":"Efficacy of DA-7218, a new oxazolidinone prodrug, in the treatment of experimental actinomycetoma produced by <italic>Nocardia brasiliensis<\/italic>.","volume":"13","author":"NA Espinoza-Gonz\u00e1lez","year":"2008","journal-title":"Molecules"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.00148-08","article-title":"In vivo therapeutic effect of gatifloxacin on BALB\/c mice infected with <italic>Nocardia brasiliensis<\/italic>.","volume":"52","author":"A Daw-Garza","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.jpba.2006.12.019","article-title":"Simultaneous determination and validation of antimicrobials in plasma and tissue of actinomycetoma by high-performance liquid chromatography with diode array and fluorescence detection.","volume":"43","author":"N Cavazos-Rocha","year":"2007","journal-title":"J Pharm Biomed Anal"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1128\/AAC.48.2.659-662.2004","article-title":"Pharmacokinetics of DA-7867, a new oxazolidinone, after intravenous or oral administration to rats: intestinal first-pass effect.","volume":"48","author":"SK Bae","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1056\/NEJMoa055191","article-title":"Outpatient gatifloxacin therapy and dysglycemia in older adults.","volume":"354","author":"LY Park-Wyllie","year":"2006","journal-title":"N Engl J Med"},{"key":"ref16","first-page":"128","article-title":"A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.","volume":"12","author":"R Rustomjee","year":"2008","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0000289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T23:03:18Z","timestamp":1540249398000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0000289"}},"subtitle":[],"editor":[{"given":"Sara","family":"Lustigman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,9,10]]},"references-count":16,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2008,9,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0000289","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1119566.575779","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,10]]}}}